News
Novavax is undervalued, presenting an attractive risk-reward profile for long-term investors. Click here to find out why NVAX ...
Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
For years, U.S. vaccine experts have issued a universal recommendation for Covid vaccines. That could change soon.
Robert F. Kennedy Jr.'s "make America healthy again" is basically Lysenko 2.0. It's come to the NIH and is destroying the crown jewel of US biomedical research with ideology and cronyism.
Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the Centers for Disease Control and ...
Proposed cuts threaten health insurance for tens of millions, tariffs will drive up drug prices, and key programs are being ...
President Donald Trump's nominee for U.S. surgeon general, Dr. Casey Means, has appeared on numerous wellness and right-wing ...
President Donald Trump's pick for surgeon general, wellness influencer and Robert F. Kennedy Jr.-ally Casey Means, is big ...
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
Pfizer (NYSE:PFE) is one of the world’s largest pharmaceutical companies, but at $22.59 per share as of this writing, the ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results